Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Differential effects of gefitinib and cetuximab on EGFR mutant non-small cell lung cancers

Differential effects of gefitinib and cetuximab on EGFR mutant non-small cell lung cancers. J Natl Cancer Inst. 2005; (97):1185-1194.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.